Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Meydan

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcomeVijendra Ramlall, Phyllis M Thangaraj, Cem Meydan, et al.
Genome Research|June 24, 2021
Haplotype diversity and sequence heterogeneity of human telomeresKirill Grigorev, Jonathan Foox, Daniela Bezdan, et al.
Nature Communications|February 20, 2019
Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune responseXabier Agirre, Cem Meydan, Yanwen Jiang, et al.
Blood|January 13, 2017
<i>Aid</i> is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cellsHiroyoshi Kunimoto, Anna Sophia McKenney, Cem Meydan, et al.
Nature Medicine|August 5, 2020
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infectionVijendra Ramlall, Phyllis M Thangaraj, Cem Meydan, et al.
NAR Genomics and Bioinformatics|October 20, 2023
Elevated A-to-I RNA editing in COVID-19 infected individualsRona Merdler-Rabinowicz, David Gorelik, Jiwoon Park, et al.
Cancer Cell|December 26, 2017
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor SensitivityHiroyoshi Kunimoto, Cem Meydan, Abbas Nazir, et al.
Genomics|January 25, 2022
Betacoronavirus-specific alternate splicingGuy Karlebach, Bruce Aronow, Stephen B Baylin, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2021
Betacoronavirus-specific alternate splicingGuy Karlebach, Bruce Aronow, Stephen B Baylin, et al.
Blood|September 10, 2020
BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cellsKimihito C Kawabata, Hongliang Zong, Cem Meydan, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Identification of Immune complement function as a determinant of adverse SARS-CoV-2 infection outcomeVijendra Ramlall, Phyllis M Thangaraj, Cem Meydan, et al.
Genome Research|June 24, 2021
Haplotype diversity and sequence heterogeneity of human telomeresKirill Grigorev, Jonathan Foox, Daniela Bezdan, et al.
Nature Communications|February 20, 2019
Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune responseXabier Agirre, Cem Meydan, Yanwen Jiang, et al.
Blood|January 13, 2017
<i>Aid</i> is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cellsHiroyoshi Kunimoto, Anna Sophia McKenney, Cem Meydan, et al.
Nature Medicine|August 5, 2020
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infectionVijendra Ramlall, Phyllis M Thangaraj, Cem Meydan, et al.
NAR Genomics and Bioinformatics|October 20, 2023
Elevated A-to-I RNA editing in COVID-19 infected individualsRona Merdler-Rabinowicz, David Gorelik, Jiwoon Park, et al.
Cancer Cell|December 26, 2017
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor SensitivityHiroyoshi Kunimoto, Cem Meydan, Abbas Nazir, et al.
Genomics|January 25, 2022
Betacoronavirus-specific alternate splicingGuy Karlebach, Bruce Aronow, Stephen B Baylin, et al.
Biorxiv : the Preprint Server for Biology|July 7, 2021
Betacoronavirus-specific alternate splicingGuy Karlebach, Bruce Aronow, Stephen B Baylin, et al.
Blood|September 10, 2020
BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cellsKimihito C Kawabata, Hongliang Zong, Cem Meydan, et al.
Pageof 12